Thoracic Surgery Unit
Milano
Via Giacomo Venezian, 1, 20133 Milano MI

Dott. Solli Piergiorgio
Direttore di struttura complessa
Tipologia: Clinical Area, Complex Structure
The Thoracic Surgery Unit of the National Cancer Institute deals with the treatment of tumors of the lung, mediastinum, thoracic wall, and esophagus. It belongs to one of the longest-standing surgical schools in Italy. It was founded in the 1980s by Professor Ravasi and was the first nationally to deal exclusively with oncological Thoracic Surgery. Since 2024, it has been directed by Dr. Piergiorgio Solli. It combines a high technical and assistance level, a strong vocation for research, and an intense training program, with the aim of providing effective and safe care pathways carried out by highly specialized personnel, attentive to the needs and history of the Patient. Surgery is performed by minimizing the invasiveness of the surgical procedure. In adherence to this principle, surgical incisions have always respected all thoracic musculature. Today, thanks to the extensive experience gained in video-assisted (VATS) and robot-assisted (RATS) techniques, the invasiveness of the surgical procedure has been further reduced, and pulmonary and mediastinal resections are performed without opening the chest, where possible. Our structure is a national reference centre for the treatment of
both high-complexity thoracic tumors and rare thoracic tumors that require multidisciplinary expertise. Specifically, it has large experience in mediastinal surgery (with vascular reconstruction), thoracic wall surgery, metastases surgery (with lung tissue sparing), sarcoma surgery, esophageal surgery, and pediatric surgery. The close cooperation with anesthetists and resuscitators has allowed for excellent results over the years in terms of patient safety, even in such complex surgery. Surgery can sometimes be preceded by a complex diagnostic phase or require pre-operative treatment. It is therefore important that the Patient is evaluated, at diagnosis, by all specialists who will participate in their care pathway. For this reason, the Multidisciplinary Thoracic Oncology Group has been active since 2011, bringing together thoracic surgeons, oncologists, and radiation oncologist highly specialized in thoracic pathology, radiologists (specialized in thoracic pathology, lung cancer screening, and interventional methods), endoscopists, pulmonologists, anatomopathologists, and nuclear medicine physicians on a weekly basis to define the best diagnostic and treatment strategy for each case, in light of international protocol indications. Patients who are candidates for surgical intervention are promptly included in a dedicated pre-hospitalization pathway for both preoperative clinical and radiological examinations and a prehabilitation pathway within the ERAS (Enhanced Recovery After Surgery) protocol, aimed at ensuring optimal recovery and an early and safe return to daily activities after operation. Specifically, this protocol may include a comprehensive functional evaluation including preoperative physiotherapy, assessment and correction of nutritional needs, correction of tumor-related chronic anemias, and pain control.
During hospitalization, within the ERAS protocol, the patient is assisted by a specialized nursing team according to an organizational model of personalized assistance (identification of the primary nurse). Furthermore, in the context of research, dedicated Research Nurse support is provided for all patients participating in clinical trials. Clinical Research Over the years, the research vocation of the Thoracic Surgery Unit has translated into participation in multiple research projects, with several publications in international journals with impact factors (link publications*). Specifically, our Structure deals with: · clinical research, by virtue of the large case series accumulated over decades and cooperation with other disciplines and with other Italian and International centers for the creation of multicentric projects and databases; · translational research (thanks to intense collaboration with the experimental oncology group that also focuses on lung cancer) with multiple innovative research lines in the early diagnosis of lung cancer that combine the use of biomarkers in the blood with the use of spiral CT. Excellence also means continuous training, without which any result cannot be maintained over time. For this purpose, Thoracic Surgery annually offers a structured ECM accredited training program dedicated to Doctors and focused on multidisciplinary management and evaluation. Collaborations The Complex Structure Thoracic Surgery also provides its expertise within existing collaborations with: - IRCCS Policlinico San Donato - Cardiac Surgery for the surgical treatment of complex mediastinal neoplasms requiring cardiovascular reconstruction or extracorporeal circulation; - IRCCS Ospedale San Gerardo dei Tintori di Monza (Complex Structure Plastic Surgery) for functional brachial plexus surgery; - IRCCS Istituto Neurologico "Carlo Besta" for the treatment of The Thoracic Surgery Unit of the National Cancer Institute deals with the treatment of tumors of the lung, mediastinum, thoracic wall, and esophagus. It belongs to one of the longest-standing surgical schools in Italy. It was founded in the 1980s by Professor Ravasi and was the first nationally to deal exclusively with oncological Thoracic Surgery. Since 2024, it has been directed by Dr. Piergiorgio Solli. It combines a high technical and assistance level, a strong vocation for research, and an intense training program, with the aim of providing effective and safe care pathways carried out by highly specialized personnel, attentive to the needs and history of the Patient. Surgery is performed by minimizing the invasiveness of the surgical procedure. In adherence to this principle, surgical incisions have always respected all thoracic musculature. Today, thanks to the extensive experience gained in video-assisted (VATS) and robot-assisted (RATS) techniques, the invasiveness of the surgical procedure has been further reduced, and pulmonary and mediastinal resections are performed without opening the chest, where possible. Our structure is a national reference centre for the treatment of
both high-complexity thoracic tumors and rare thoracic tumors that require multidisciplinary expertise. Specifically, it has large experience in mediastinal surgery (with vascular reconstruction), thoracic wall surgery, metastases surgery (with lung tissue sparing), sarcoma surgery, esophageal surgery, and pediatric surgery. The close cooperation with anesthetists and resuscitators has allowed for excellent results over the years in terms of patient safety, even in such complex surgery. Surgery can sometimes be preceded by a complex diagnostic phase or require pre-operative treatment. It is therefore important that the Patient is evaluated, at diagnosis, by all specialists who will participate in their care pathway. For this reason, the Multidisciplinary Thoracic Oncology Group has been active since 2011, bringing together thoracic surgeons, oncologists, and radiation oncologist highly specialized in thoracic pathology, radiologists (specialized in thoracic pathology, lung cancer screening, and interventional methods), endoscopists, pulmonologists, anatomopathologists, and nuclear medicine physicians on a weekly basis to define the best diagnostic and treatment strategy for each case, in light of international protocol indications. Patients who are candidates for surgical intervention are promptly included in a dedicated pre-hospitalization pathway for both preoperative clinical and radiological examinations and a prehabilitation pathway within the ERAS (Enhanced Recovery After Surgery) protocol, aimed at ensuring optimal recovery and an early and safe return to daily activities after operation. Specifically, this protocol may include a comprehensive functional evaluation including preoperative physiotherapy, assessment and correction of nutritional needs, correction of tumor-related chronic anemias, and pain control.
During hospitalization, within the ERAS protocol, the patient is assisted by a specialized nursing team according to an organizational model of personalized assistance (identification of the primary nurse). Furthermore, in the context of research, dedicated Research Nurse support is provided for all patients participating in clinical trials. Clinical Research Over the years, the research vocation of the Thoracic Surgery Unit has translated into participation in multiple research projects, with several publications in international journals with impact factors (link publications*). Specifically, our Structure deals with: · clinical research, by virtue of the large case series accumulated over decades and cooperation with other disciplines and with other Italian and International centers for the creation of multicentric projects and databases; · translational research (thanks to intense collaboration with the experimental oncology group that also focuses on lung cancer) with multiple innovative research lines in the early diagnosis of lung cancer that combine the use of biomarkers in the blood with the use of spiral CT. Excellence also means continuous training, without which any result cannot be maintained over time. For this purpose, Thoracic Surgery annually offers a structured ECM accredited training program dedicated to Doctors and focused on multidisciplinary management and evaluation. Collaborations The Complex Structure Thoracic Surgery also provides its expertise within existing collaborations with: - IRCCS Policlinico San Donato - Cardiac Surgery for the surgical treatment of complex mediastinal neoplasms requiring cardiovascular reconstruction or extracorporeal circulation; - IRCCS Ospedale San Gerardo dei Tintori di Monza (Complex Structure Plastic Surgery) for functional brachial plexus surgery; - IRCCS Istituto Neurologico "Carlo Besta" for the treatment of The Thoracic Surgery Unit of the National Cancer Institute deals with the treatment of tumors of the lung, mediastinum, thoracic wall, and esophagus. It belongs to one of the longest-standing surgical schools in Italy. It was founded in the 1980s by Professor Ravasi and was the first nationally to deal exclusively with oncological Thoracic Surgery. Since 2024, it has been directed by Dr. Piergiorgio Solli. It combines a high technical and assistance level, a strong vocation for research, and an intense training program, with the aim of providing effective and safe care pathways carried out by highly specialized personnel, attentive to the needs and history of the Patient. Surgery is performed by minimizing the invasiveness of the surgical procedure. In adherence to this principle, surgical incisions have always respected all thoracic musculature. Today, thanks to the extensive experience gained in video-assisted (VATS) and robot-assisted (RATS) techniques, the invasiveness of the surgical procedure has been further reduced, and pulmonary and mediastinal resections are performed without opening the chest, where possible. Our structure is a national reference centre for the treatment of
both high-complexity thoracic tumors and rare thoracic tumors that require multidisciplinary expertise. Specifically, it has large experience in mediastinal surgery (with vascular reconstruction), thoracic wall surgery, metastases surgery (with lung tissue sparing), sarcoma surgery, esophageal surgery, and pediatric surgery. The close cooperation with anesthetists and resuscitators has allowed for excellent results over the years in terms of patient safety, even in such complex surgery. Surgery can sometimes be preceded by a complex diagnostic phase or require pre-operative treatment. It is therefore important that the Patient is evaluated, at diagnosis, by all specialists who will participate in their care pathway. For this reason, the Multidisciplinary Thoracic Oncology Group has been active since 2011, bringing together thoracic surgeons, oncologists, and radiation oncologist highly specialized in thoracic pathology, radiologists (specialized in thoracic pathology, lung cancer screening, and interventional methods), endoscopists, pulmonologists, anatomopathologists, and nuclear medicine physicians on a weekly basis to define the best diagnostic and treatment strategy for each case, in light of international protocol indications. Patients who are candidates for surgical intervention are promptly included in a dedicated pre-hospitalization pathway for both preoperative clinical and radiological examinations and a prehabilitation pathway within the ERAS (Enhanced Recovery After Surgery) protocol, aimed at ensuring optimal recovery and an early and safe return to daily activities after operation. Specifically, this protocol may include a comprehensive functional evaluation including preoperative physiotherapy, assessment and correction of nutritional needs, correction of tumor-related chronic anemias, and pain control.
During hospitalization, within the ERAS protocol, the patient is assisted by a specialized nursing team according to an organizational model of personalized assistance (identification of the primary nurse). Furthermore, in the context of research, dedicated Research Nurse support is provided for all patients participating in clinical trials.
Over the years, the research vocation of the Thoracic Surgery Unit has translated into participation in multiple research projects, with several publications in international journals with impact factors (link publications*). Specifically, our Structure deals with:
- clinical research, by virtue of the large case series accumulated over decades and cooperation with other disciplines and with other Italian and International centers for the creation of multicentric projects and databases;
- translational research (thanks to intense collaboration with the experimental oncology group that also focuses on lung cancer) with multiple innovative research lines in the early diagnosis of lung cancer that combine the use of biomarkers in the blood with the use of spiral CT.
Excellence also means continuous training, without which any result cannot be maintained over time. For this purpose, Thoracic Surgery annually offers a structured ECM accredited training program dedicated to Doctors and focused on multidisciplinary management and evaluation.
The Complex Structure Thoracic Surgery also provides its expertise within existing collaborations with:
- IRCCS Policlinico San Donato - Cardiac Surgery for the surgical treatment of complex mediastinal neoplasms requiring cardiovascular reconstruction or extracorporeal circulation;
- IRCCS Ospedale San Gerardo dei Tintori di Monza (Complex Structure Plastic Surgery) for functional brachial plexus surgery;
- IRCCS Istituto Neurologico "Carlo Besta" for the treatment of thoracic wall or lung neoplasms involving the vertebral column.
For medical training, the following collaborations are present:
- University of Milan, Specialization School in Thoracic Surgery
- SICT - Minimally Invasive Surgery Training Course and Advanced Robotic Surgery Master.
An international Observership program is active, which sees the presence of foreign visitors interested in deepening the clinical management of patients affected by thoracic pathology; in particular, a collaboration agreement with China has recently been stipulated.
For a visit (Access mode only SSN - National Health Service) First thoracic surgery visits are performed on Wednesdays, Thursdays, and Fridays. The waiting list is about 1 week. First multidisciplinary visits (CAT) are performed on Mondays and Thursdays. Bookings can be made: by calling the CUP, at number (+39) 02 23901 (from 8:30 to 16:00 from Monday to Friday) by sending an email to segreteria.chirurgiatoracica@istitutotumori.mi.it (for first thoracic surgery visits) by sending an email to miriam.fink@istitutotumori.mi.it (for first CAT visits) For any type of booking (even by phone), it is necessary to have the health card, tax code, and the medical prescription for "First thoracic surgical visit" (for surgical visits) or "Multidisciplinary CAT Visit" bearing as diagnostic query "suspicion of neoplasia of" (lung, pleura, thymus). To book follow-up visits, please contact the CUP during the indicated hours with an electronic prescription. For Telemedicine visits, please contact the CUP during the indicated hours. Outpatient visits are carried out on the Ground Floor, at the General Clinics, room G.
BioMILD: studio prospettico sull'efficacia del microRNA plasmatici come test di prima linea per la diagnosi precoce del cancro polmonare
RISP: Studio randomizzato di prevenzione primaria multifattoriale in soggetti ad alto rischio eleggibili a screening con TC torace
MDT BRIDGE: Studio interventistico, multicentrico, di fase II, a braccio singolo sulla terapia neoadiuvante con durvalumab e chemioterapia (CT) a base di platino, seguito da intervento chirurgico e terapia adiuvante con durvalumab o chemioradioterapia (CRT) e terapia di consolidamento con durvalumab, in partecipanti con tumore polmonare non a piccole cellule (NSCLC) resecabile o borderline resecabile in stadio IIB-IIIB
Every day from 11:00 AM to 12:00 PM and from 4:00 PM to 6:00 PM.
To book an appointment, write to chiara.banfi@istitutotumori.mi.it or directly to the reference doctor.
- Mail: segreteria.chirurgiatoracica@istitutotumori.mi.it
- Tel: 0223902384
The preferred and fastest communication method is by email.
Dott. Solli Piergiorgio
Direttore di struttura complessa
Dott. Tavecchio Luca
Medical Director
Dott. Ferrari Michele
Medical Director
Dott. Leuzzi Giovanni
Medical Director
Dott.ssa Stanzi Alessia
Medical Director
Dirigenti Medici:
Dr. DURANTI Leonardo
Dr. PARDOLESI Alessandro
Dr. ROLLI LUIGI
Medici Specializzandi:
Dr. CALDERONI Matteo
Dr. CERUTI Edoardo
Dr.ssa USLENGHI Clarissa
Segreteria:
Sig.ra VOLPIN Marzia
Coordinatrice infermieristica:
Dott.ssa CAPPELLINI Sonia
Attività scientifiche:
BANFI Chiara
CALANCA Anna Maria
EL HAYEK Mariam
GHIDOLI Chiara
JACOMELLI Claudio
LEDDA Roberta Eufrasia
NINNI Carolina
SABIA Federica
SUATONI Paola
Biomarcatori del sangue per la predizione del rischio e la prognosi del cancro polmonare in individui con noduli polmonari rilevati dalla tomografia computerizzata a bassa dose (LDCT) della coorte Rete Italiana Screening Polmonare (RISP).
Biomarcatori del sangue per la predizione del rischio e la prognosi del cancro polmonare in individui con noduli polmonari rilevati dalla tomografia computerizzata a bassa dose (LDCT) della coorte Rete Italiana Screening Polmonare (RISP).
Last update: 16/09/2025